Complement promotes endothelial von Willebrand factor and angiopoietin-2 release in obstructive sleep apnea

Abstract

IH promotes the complement-mediated release of vWF and angiopoietin-2, which may contribute to pro-thrombotic and pro-inflammatory conditions in OSA. Statin reversed these effects, suggesting a potential approach to reduce cardiovascular risk in OSA.